- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Drug Discovery Services Market is expected to reach US$ 56,783.29 million by 2030
Nov 17, 2023
Patient-Derived Xenograft Model Market is expected to reach US$ 975.31 million by 2030
Feb 06, 2024
Diabetic Foot Ulcer Market is expected to reach US$ 12,242.77 million by 2030
Sep 14, 2023
Middle East and Africa Botulinum Toxin Market is expected to reach US$ 453.55 million by 2030
Dec 06, 2023
Geneyork Pharmaceutical Announces U.S. Launch of Generic Version of Deltasone® (Prednisone) Tablets
Feb 03, 2020
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Sep 17, 2019
Vaccines: A Powerful Panacea to Impound Epidemic
Aug 19, 2019
Follow us on
